StockData
Retension Pharmaceuticals, Inc. logo

Retension Pharmaceuticals, Inc. (RTSN) SEC filings

RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 18, 2026
$11.41−0.05 (-0.44%)

Close on Nov 17, 2026Market cap $9.22MP/E –Yield –

SEC filings

4 of Retension Pharmaceuticals's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 18, 2026SEC EDGAR
Current report8-KNov 18, 2026Nov 18, 2026SEC EDGAR
Current report8-KOct 21, 2026Oct 23, 2026SEC EDGAR
Current report8-KOct 9, 2026Oct 13, 2026SEC EDGAR

See a number that looks wrong?